Skip to Content

BMS 100 mg 3623 (Reyataz 100 mg)

Generic Name: atazanavir

Pill with imprint BMS 100 mg 3623 is Blue & White, Capsule-shape and has been identified as Reyataz 100 mg. It is supplied by Bristol-Myers Squibb.

Reyataz is used in the treatment of nonoccupational exposure; hiv infection and belongs to the drug class protease inhibitors. There is no proven risk in humans during pregnancy. Reyataz 100 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for BMS 100 mg 3623

Reyataz

Generic Name:
atazanavir
Imprint:
BMS 100 mg 3623
Strength:
100 mg
Color:
Blue & White
Size:
18.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Protease inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Bristol-Myers Squibb
National Drug Code (NDC):
00003-3623
Inactive Ingredients:

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide